Controlled trials show no clear benefit of inhaled opioids over oral or i.v. administration in the treatment of dyspnea. Low-dose oral or sublingual opioids are effective in treating dyspnea.

Do cough, cold or other respiratory issues disrupt your sleep in the rising air pollution? Explore the best nebulizer ...

Participants in the trial were symptomatic despite treatment with standard of care (intranasal corticosteroids [INCS]). 1 Dr. Joseph Han, Vice Chair of Rhinology & Endoscopic Sinus and Skull Base ...

These preclinical findings could lead ... Single-Dose Gene Therapy Is Potentially Life-Changing for Adults With Hemophilia B Sep. 25, 2024 — Adults with hemophilia B saw their number of bleeding ...

Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that senior management will present a company ...

Treatment to reduce asthma-related morbidity ... Acute chest syndrome; BD: Bronchodilator; CSSCD: Cooperative Study of Sickle Cell Disease; ICD: International classification of diseases; ISAAC ...

Ohtuvayre™ (ensifentrine) launch recorded Q3 net sales of $5.6 million and October net sales exceeded Q3Through October more than 2,200 unique ...

At the same time, medications used to treat asthma, such as inhaled bronchodilators and corticosteroids ... Asthma is a potentially reversible condition when the right treatment is received at the ...

Amgen and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]). The trial ...